NYU LANGONE HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1841-01-01

Employees: 10K

Market Cap: -

Website: http://www.nyulangone.org

Clinical Trials

Extended-Release vs. Oral Naltrexone Alcohol Treatment in Primary Care

Phase 4

Completed

Conditions: Alcohol Dependence

Interventions: Drug: XR-NTX (Extended-Release Naltrexone)
Drug: Oral Naltrexone (O-NTX)

First Posted Date: 2013-07-09

Last Posted Date: 2020-06-16

Lead Sponsor: NYU Langone Health

Target Recruit Count: 237

Registration Number: NCT01893827

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Tolvaptan to Reduce Length of Stay in Hospitalized Patients With Cirrhosis and Hyponatremia

Phase 4

Terminated

Conditions: Hyponatremia

Interventions: Drug: Placebo
Drug: Tolvaptan
Behavioral: Hepatic Encephalopathy Assessment
Behavioral: Quality of Life Assessment
Biological: Vital signs
Biological: Blood laboratory tests
Procedure: Ascites Evaluation
Procedure: Edema

First Posted Date: 2013-07-02

Last Posted Date: 2017-12-11

Lead Sponsor: NYU Langone Health

Target Recruit Count: 2

Registration Number: NCT01890694

Locations: 🇺🇸
NYU Langone Medical Center, New York, New York, United States

Effect of Music on Attention and Prospective Memory in Hepatic Encephalopathy

Withdrawn

Conditions: Cirrhosis
Hepatic Encephalopathy

First Posted Date: 2013-06-20

Last Posted Date: 2016-03-11

Lead Sponsor: NYU Langone Health

Registration Number: NCT01882855

Locations: 🇺🇸
NYU Medical Center, New York, New York, United States

Evaluation of PET/MR and PET/CT Imaging for Bone Marrow Lesions

Completed

Conditions: Multiple Myeloma
Osteoporosis
Disease of the Marrow

First Posted Date: 2013-06-19

Last Posted Date: 2016-12-02

Lead Sponsor: NYU Langone Health

Target Recruit Count: 44

Registration Number: NCT01880762

Locations: 🇺🇸
NYU Center for Biomedical Imaging, New York, New York, United States

Exploring the Activity of RAD001 in Vestibular Schwannomas and Meningiomas

Early Phase 1

Completed

Conditions: Neurofibromatosis Type 2
Vestibular Schwannomas
Meningiomas

Interventions: Drug: RAD001

First Posted Date: 2013-06-19

Last Posted Date: 2020-05-13

Lead Sponsor: NYU Langone Health

Target Recruit Count: 5

Registration Number: NCT01880749

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Mobile Insulin Titration Intervention

Not Applicable

Completed

Conditions: Diabetes Mellitus

Interventions: Other: Mobile Insulin Titration Intervention

First Posted Date: 2013-06-18

Last Posted Date: 2015-10-12

Lead Sponsor: NYU Langone Health

Target Recruit Count: 61

Registration Number: NCT01879579

Locations: 🇺🇸
Adult Primary Care Clinic, Bellevue Hospital Center, New York, New York, United States

The Effects of Cold Liquids on the Swallowing Mechanism in Preterm Infants

Not Applicable

Completed

Conditions: Dysphagia

Interventions: Other: Cold Thin Liquid Barium

First Posted Date: 2013-05-27

Last Posted Date: 2019-02-06

Lead Sponsor: NYU Langone Health

Target Recruit Count: 10

Registration Number: NCT01863264

Locations: 🇺🇸
Winthrop University Hospital, Mineola, New York, United States

School-Based Mental Health Program Implementation in Uganda

Not Applicable

Completed

Conditions: Teacher Mental Health Knowledge
Teacher Skills in Addressing Child Mental Health Problem

Interventions: Behavioral: ParentCorps

First Posted Date: 2013-05-20

Last Posted Date: 2016-03-31

Lead Sponsor: NYU Langone Health

Target Recruit Count: 79

Registration Number: NCT01857388

Locations: 🇺🇬
Makerere University, Kampala, Uganda

Promoting Safe Use of Pediatric Liquid Medications

Not Applicable

Completed

Conditions: Medication Errors

Interventions: Other: New Labeling/Dosing Strategy

First Posted Date: 2013-05-15

Last Posted Date: 2024-05-17

Lead Sponsor: NYU Langone Health

Target Recruit Count: 1005

Registration Number: NCT01854151

Locations: 🇺🇸
Stanford University School of Medicine, Stanford, California, United States
🇺🇸
Emory University School of Medicine, Atlanta, Georgia, United States
🇺🇸
New York University School of Medicine, New York, New York, United States

and more 1 locations

Effects Contrast on Platelet Activity, Thrombosis and Fibrinolysis in Patients Undergoing Coronary Angiography

Phase 4

Completed

Conditions: Coronary Artery Disease

Interventions: Drug: Ioxaglate
Drug: Iodixanol
Drug: Bivalirudin

First Posted Date: 2013-05-08

Last Posted Date: 2016-04-06

Lead Sponsor: NYU Langone Health

Target Recruit Count: 100

Registration Number: NCT01848899

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy